Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lixte Biotechnology Holdings, Inc. - Common Stock
(NQ:
LIXT
)
1.450
+0.050 (+3.57%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lixte Biotechnology Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
BABA Stock Alert: Alibaba Tests AI Tool to Compete With ChatGPT
February 08, 2023
Alibaba (BABA) stock is on the move Wednesday as investors react to news of the company testing an AI tool to rival ChatGPT.
Via
InvestorPlace
Why Is Lixte Biotech (LIXT) Stock Down 29% Today?
February 08, 2023
Lixte Biotech (LIXT) stock is dropping on Wednesday but it's not due to any negative news from the drug discovery company.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 08, 2023
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!
Via
InvestorPlace
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
February 08, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares rose 89.5% to $0.9475 in pre-market trading. PainReform reported receipt of extension to Aug. 7, 2023 to meet the Nasdaq's minimum bid price requirement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 07, 2023
Via
Benzinga
Dow Turns Higher; Crude Oil Rises Over 3%
February 07, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 80 points on Tuesday. The Dow traded up 0.05% to 33,906.31 while the NASDAQ rose 0.69% to 11,969.79. The S&P...
Via
Benzinga
LIXTE Biotechnology Stock Jumps As Lead Program Shows Cancer Killing Activity In Animal Models
February 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 09, 2023
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Bright Health And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
December 19, 2022
The Nasdaq 100 index closed lower by over 100 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
LIXTE BIOTECHNOLOGY ANNOUNCES APPROVAL OF A PHASE 1B/2 RANDOMIZED TRIAL OF DOXORUBICIN +/-LB-100 IN ADVANCED SOFT TISSUE SARCOMAS TO BE CONDUCTED BY THE SPANISH SARCOMA GROUP
October 13, 2022
From
Lixte Biotechnology Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 30, 2022
Gainers Ainos (NASDAQ:AIMD) shares increased by 46.4% to $2.02 during Friday's pre-market session. The market value of their outstanding shares is at $39.3 million.
Via
Benzinga
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
September 27, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 26, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 01, 2022
Gainers SenesTech (NASDAQ:SNES) stock rose 28.0% to $0.64 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 15, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 08, 2022
Via
Benzinga
Twitter And 20 Stocks Moving Premarket
July 08, 2022
Gainers Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 10, 2022
Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day...
Via
Benzinga
Short Squeeze Stocks: RDBX, MDVL and 3 Others Experts Think Are Ready to Pop
May 09, 2022
Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel's top short squeeze candidates.
Via
InvestorPlace
99 Biggest Movers From Yesterday
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.